BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:Meaningful progress in establishing causative genetic mutation
 s and environmental factors implicated in ALS disease progression and adv
 ances in validating emerging biomarkers to evaluate treatment response ha
 s meant that the landscape for drug development in ALS is exploding. With
  exciting new targets\, revised inclusion criteria\, and opportunities to
  implement digital biomarkers for remote and sensitive monitoring\, we ha
 ve never been closer to bringing meaningful therapies to patients.\n\nUni
 ting industry experts dedicated to accelerating effective therapeutic app
 roaches\, the ALS Drug Development Summit is the definitive industry foru
 m sharing cross-industry insight to rapidly advance life-changing ALS the
 rapeutics.\n\nFrom dissecting exciting progress in small molecules and ge
 ne therapy to clarifying sensitive primary outcome measures beyond ALSFRS
 -R\, join industry experts from Biogen\, Eli Lilly\, Mitsubishi Tanabe Ph
 arma\, Sanofi\, ProMIS Neurosciences\, Cytokinetics\, Brainstorm Cell The
 rapeutics and many more to drive progress towards slowed disease progress
 ion and improved outcomes in ALS.\n
DTEND:20220526T163000
DTSTAMP:20260512T223113Z
DTSTART:20220524T090000
LOCATION:Hyatt Regency Boston\, 1\, Avenue de Lafayette\, Boston\, Suffolk
  County\, 02111\,
SEQUENCE:0
SUMMARY:Meaningful progress in establishing causative genetic mutations an
 d environmental factors implicated in ALS disease progression and advance
 s in val...
UID:f8674ac1-5cf5-4178-b4a6-a5e511550def
END:VEVENT
END:VCALENDAR